News

Wednesday June, 19, 2013

MIVAC Development as part of the Universal Influenza Vaccine (UNIFLUVAC) network, was supported by the FP7-PEOPLE-2013-ITN grant.

Tuesday, December 20 2011

MIVAC Development creates a new company, Toleranzia AB, for the spin-out of the tolerance inducing Re-TolerogenTM platform.

Thursday, November 24 2011

MIVAC development receives continued financial support from Innovationskontor Väst for the tolerance inducing Re-TolerogenTM platform.

Wednesday, August 17 2011

MIVAC Development creates a new company, Alzinova AB, for the spin-out of the AβCCTM-project.

News release

Synthon and MIVAC Development enter into exclusive research collaboration and commercial licensing agreement in multiple sclerosis.

Job position tolerance

MIVAC Development announces an opening in the area of molecular biology to strengthen the team working on our tolerance-inducing technology platform.

Wednesday, February 2 2011

MIVAC Development receives verification grants from Innovationskontor Väst for both the AβCCTM-project and for the tolerance inducing Re-TolerogenTM platform.

ARF news story

The AβCCTM invention receives attention on the Alzheimer Research Forum webpage.